LifeStance Health Group, Inc. (LFST) financials: revenue, earnings and cash flow
Fiscal 2019–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
LifeStance Health Group’s revenue went from $213M in fiscal 2019 to $1.4B in fiscal 2025, growth of about 37.3% a year.
Net income in fiscal 2025 was $10M, a net margin of 0.7%; the highest of the period.
Over the twelve months to September 30, 2026, revenue was $1.7B and net income $72M.
Free cash flow was $110M in fiscal 2025 and positive in 3 of the 6 years shown.
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.7B | $1.4B | $1.3B | $1.1B | $860M | $668M | $213M |
| Gross profit | — | — | — | — | — | — | — |
| Operating income | $104M | $24M | -$32M | -$189M | -$210M | -$286M | $15M |
| Net income | $72M | $10M | -$57M | -$186M | -$216M | -$307M | $6M |
| EPS (diluted) | $0.19 | $0.02 | $-0.15 | $-0.51 | $-0.61 | $-0.00 | — |
| R&D | — | — | — | — | — | — | — |
| Revenue growth | — | +13.9% | +18.5% | +22.8% | +28.8% | +214.1% | — |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $228M | $146M | $107M | -$17M | $53M | $9M | $17M |
| Capital spending | -$48M | -$36M | -$22M | -$41M | -$79M | -$94M | -$14M |
| Free cash flow | $179M | $110M | $86M | -$57M | -$26M | -$85M | $3M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | — | — | — | — | — | — | — |
| Stock-based pay | $70M | $75M | $76M | $99M | $187M | $259M | $54000 |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2019 |
|---|---|---|---|---|---|---|---|
| Cash | — | $249M | $155M | $79M | $109M | $148M | $3M |
| Debt | — | $477M | $488M | $517M | $485M | $161M | — |
| Equity | — | $1.5B | $1.4B | $1.4B | $1.5B | $1.5B | -$166M |
| Total assets | — | $2.2B | $2.1B | $2.1B | $2.2B | $1.9B | — |
| Shares (diluted) | 391M | 391M | 379M | 367M | 355M | 328M | — |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2019 |
|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — |
| Operating margin | 6.2% | 1.7% | -2.5% | -17.9% | -24.4% | -42.9% | 7.2% |
| Net margin | 4.3% | 0.7% | -4.6% | -17.6% | -25.1% | -46.0% | 2.7% |
| FCF margin | 10.7% | 7.7% | 6.9% | -5.4% | -3.1% | -12.7% | 1.3% |
| ROIC | — | 0.9% | -1.6% | -8.8% | -9.7% | -15.5% | — |
| ROE | — | 0.6% | -4.0% | -13.0% | -14.2% | -19.9% | -3.4% |
Frequently asked questions
What is LifeStance Health Group’s annual revenue?
$1.4B in fiscal 2025 and $1.7B over the twelve months to September 30, 2026.
How much profit does LifeStance Health Group make?
Net income was $10M in fiscal 2025 (net margin 0.7%).
Is LifeStance Health Group’s revenue growing?
Yes: revenue rose 13.9% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.